kimberly-clark kenvue

Kimberly-Clark bets $40 billion on Kenvue

Kimberly-Clark to Buy Tylenol Maker Kenvue. Why the Stock Market Hates the Deal.

Kimberly-Clark agreed to buy Kenvue in a cash-and-stock transaction that values the Tylenol maker at an enterprise value of about $48.7 billion, including debt. Under the terms of the deal, Kenvue shareholders will receive $21.

· 10h · on MSN

Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue

· 10h · on MSN

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

13h

Kimberly-Clark Agrees to Buy Kenvue, Maker of Tylenol, for $40 Billion

The owner of Kleenex and Huggies will acquire the embattled company, which has fought claims by the Trump administration that a common pain reliever is linked to harmful side effects.

13hon MSN

These Stocks Are Moving the Most Today: Kenvue, Kimberly-Clark, Amazon, uniQure, Palantir, Idexx, Cipher Mining, and More

Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.

20hon MSN

Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

4don MSN

Kimberly-Clark Profit Falls, Organic Sales Rise

Kimberly-Clark’s third-quarter profit fell 51% as a result of divestitures, business exits and recent tariffs, although sales ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results